Collegium Pharmaceutical ... (COLL)
33.15
-0.64 (-1.89%)
At close: Jan 14, 2025, 3:59 PM
33.18
0.09%
After-hours Jan 14, 2025, 04:00 PM EST
Company Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management.
Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment.
The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003.
Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Collegium Pharmaceutical Inc.
| Country | United States |
| IPO Date | May 7, 2015 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 197 |
| CEO | Vikram Karnani |
Contact Details
Address: 100 Technology Center Drive Stoughton, Massachusetts United States | |
| Website | https://www.collegiumpharma.com |
Stock Details
| Ticker Symbol | COLL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001267565 |
| CUSIP Number | 19459J104 |
| ISIN Number | US19459J1043 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Vikram Karnani | Chief Executive Officer, President & Director |
| Colleen Tupper | Executive Vice President & Chief Financial Officer |
| Bart J. Dunn | Executive Vice President of Strategy & Corporate Development |
| Dr. Christopher Shayne James M.D. | Vice President of Investor Relations |
| Dr. Thomas B. Smith FAAFP, M.D. | Executive Vice President & Chief Medical Officer |
| Michael Thomas Heffernan B.S. Pharm, R.Ph. | Co-Founder & Chairman |
| Scott Dreyer | Executive Vice President & Chief Commercial Officer |
| Scott Sudduth | Head of Technical Operations |
| Shirley R. Kuhlmann J.D. | Executive Vice President, General Counsel, Chief Administrative Officer & Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 14, 2025 | 4 | Filing |
| Jan 08, 2025 | 8-K | Current Report |
| Nov 14, 2024 | 4 | Filing |
| Nov 14, 2024 | 3 | Filing |
| Nov 14, 2024 | 8-K/A | [Amend] Current Report |
| Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 13, 2024 | SCHEDULE 13G | Filing |
| Nov 07, 2024 | 10-Q | Quarterly Report |
| Nov 07, 2024 | 8-K | Current Report |